TC
AGN

Truvestments Capital’s Allergan plc AGN Stock Holding History

Truvestments Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-52
Closed -$9K – 644
2020
Q1 		$9K Buy
+52
New +$9.79K 0.01% 367
2019
Q4 		– Sell
-52
Closed -$9K – 686
2019
Q3 		$9K Sell
52
-3,136
-98% -$511K 0.01% 512
2019
Q2 		$534K Sell
3,188
-173
-5% -$24K 0.36% 72
2019
Q1 		$492K Buy
+3,361
New +$487K 0.38% 69
2018
Q3 		$738K Sell
3,875
-363
-9% -$66.7K 0.35% 78
2018
Q2 		$707K Buy
+4,238
New +$680K 0.44% 75

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Truvestments Capital's AGN Position: Q2 2020 in Review

Truvestments Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 52 shares — an estimated $9K sold.

Truvestments Capital first reported a position in AGN in Q2 2018 and held it in 6 quarters. The position peaked at $738K in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Truvestments Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Truvestments Capital sold 52 Allergan plc shares in Q2 2020, an estimated $9K.
  • Truvestments Capital first reported a position in Allergan plc in Q2 2018 and held it in 6 quarters.
  • Truvestments Capital's Allergan plc position peaked at $738K in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Truvestments Capital's 13F filing for Q2 2020, filed 6 Aug 2020.